The applicant is notified of the outcome of the application through a written decision from the Norwegian Medicines Agency. Any approval will include what the permit comprises, the period of validity of the permit, and may contain terms and conditions related to the deliberate release.

The applicant is obliged to follow up any terms and conditions in the approval and to report on the result of the release. In addition, there are general obligations under the law: